Beta© 2026 Adaptrex, LLC
Beta© 2026 Adaptrex, LLC
Federal grant · project grant (b)
Awards Issued Prior to January 20, 2025, Were Funded Under Previous Administrations and May Not Reflect the Priorities and Policies of the Current Administration. This Project Addresses the Ecdre Priorities a Cure for Hlb-infected Trees and Strategies for Maintaining Their Productivity and a Delivery System for Therapeutics Nutrition and Other HLB Solutions. in This Proposal We Will First Explore All Potential Uses of Nmv-m/cfl as a Biocontrol Agent to Control HLB. We Will Understand How This Virus Suppresses HLB and Identify the Best Citrus Varieties (scion and Rootstock Combinations) Which Can Tolerate High Viral and Las Titers for Application Both in New Plantings and Existing Hlb-affected Groves. Second We Will Explore Our Newly Developed Nmv-m/cfl-based Expression Vector and Optimize Its Antimicrobial or Anti-psyllid Expression and Delivery System With Known Antimicrobial Peptides or Sirna. Concurrently We Will Conduct Active Outreach and Extension Activities to Disseminate Our Project Results to Growers Stakeholders and the Public.
Committed
$1.5 Million
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…